Eugene S. Arum is a Hempstead, New York based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Eugene S. Arum is 116763 for Ophthalmology in New York. Eugene S. Arum is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Eugene S. Arum speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
226 Clinton St, Hempstead, New York, 11550-2614
Phone:
516-483-2020
Fax:
516-560-1895
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1447319413
NPI Enumeration Date:
06 Dec, 2006
NPI Last Update On:
05 Oct, 2011
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Eugene S. Arum are as mentioned below.
License Number
Specialization
State
Status
116763
Ophthalmology
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1000 Zeckendorf Blvd, Garden City, New York
Zip:
11530-2133
Phone Number:
516-542-6880
Fax Number:
516-542-5556
Patients can reach Eugene S. Arum at 226 Clinton St, Hempstead, New York or can call to book an appointment on 516-483-2020. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.